AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
Veterans diagnosed with post-traumatic stress disorder may experience thrashing sleep, which can lead to more extensive ...
The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...
Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied –– Achieved Statistical Significance with Up to 48% Slowing of Clinical ...
Our grey matter has always been a mystery, even to neurologists, but Professor Masud Husain says life-changing advances may ...
3don MSN
Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...
Alterity Therapeutics (ATHE) announced topline results from the ATH434-201 randomized, double-blind, placebo-controlled Phase 2 clinical trial ...
Gary Woodland spent much of 2023 awash in fear. He dreaded death every day — walking down the street, driving a car, boarding an airplane. His charmed life as a professional golfer gave way to ...
Unified Parkinson's Disease Rating Scale (UPDRS) scores, 8–43] and 15 healthy controls (mean age, 59.5 ± 9.4 years) underwent DKI of the substantia nigra and red nucleus. Imaging was performed using a ...
Children and young people who are Black or Hispanic are less likely to be diagnosed with migraine than those who are white when being seen for headache in a pediatric emergency department, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback